{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:32:34Z","timestamp":1793892754559,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02911"],"award-info":[{"award-number":["22H02911"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K19527"],"award-info":[{"award-number":["23K19527"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K16504"],"award-info":[{"award-number":["22K16504"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,11,20]]},"DOI":"10.1038\/s41416-026-03577-w","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T12:01:13Z","timestamp":1787400073000},"page":"1628-1640","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual-oxygen pancreatic cancer organoids recapitulate basal\u2013classical heterogeneity validated by spatial transcriptomics"],"prefix":"10.1038","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8032-167X","authenticated-orcid":false,"given":"Koichiro","family":"Kumano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Nakahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Owada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Kamohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Komatsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihito","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaejeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pakavarin","family":"Louphrasitthiphol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin R.","family":"Goding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1021-7911","authenticated-orcid":false,"given":"Yoshiaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamiko","family":"Sakata-Yanagimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6115-0158","authenticated-orcid":false,"given":"Tatsuya","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"3577_CR1","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"3577_CR2","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1158\/2159-8290.CD-19-1353","volume":"10","author":"E Helms","year":"2020","unstructured":"Helms E, Onate MK, Sherman MH. Fibroblast heterogeneity in the pancreatic tumor microenvironment. Cancer Discov. 2020;10:648\u201356.","journal-title":"Cancer Discov"},{"key":"3577_CR3","doi-asserted-by":"publisher","first-page":"20130676","DOI":"10.1259\/bjr.20130676","volume":"87","author":"SR McKeown","year":"2014","unstructured":"McKeown SR. Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Br J Radiol. 2014;87:20130676.","journal-title":"Br J Radiol"},{"key":"3577_CR4","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0360-3016(00)00803-8","volume":"48","author":"AC Koong","year":"2000","unstructured":"Koong AC, Mehta VK, Le QT, Fisher GA, Terris DJ, Brown JM, et al. Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys. 2000;48:919\u201322.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3577_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13045-020-01030-w","volume":"14","author":"J Tao","year":"2021","unstructured":"Tao J, Yang G, Zhou W, Qiu J, Chen G, Luo W, et al. Targeting hypoxic tumor microenvironment in pancreatic cancer. J Hematol Oncol. 2021;14:14.","journal-title":"J Hematol Oncol"},{"key":"3577_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/0008-5472.CAN-22-2045","volume":"83","author":"SJ Park","year":"2023","unstructured":"Park SJ, Yoo HC, Ahn E, Luo E, Kim Y, Sung Y, et al. Enhanced glutaminolysis drives hypoxia-induced chemoresistance in pancreatic cancer. Cancer Res. 2023;83:735\u201352.","journal-title":"Cancer Res"},{"key":"3577_CR7","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-13-3009","volume":"74","author":"X Zhao","year":"2014","unstructured":"Zhao X, Gao S, Ren H, Sun W, Zhang H, Sun J, et al. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. Cancer Res. 2014;74:2455\u201364.","journal-title":"Cancer Res"},{"key":"3577_CR8","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","volume":"2","author":"L Schito","year":"2016","unstructured":"Schito L, Semenza GL. Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer. 2016;2:758\u201370.","journal-title":"Trends Cancer"},{"key":"3577_CR9","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/S0002-9440(10)65054-7","volume":"156","author":"RH Hruban","year":"2000","unstructured":"Hruban RH, Wilentz RE, Kern SE. Genetic progression in the pancreatic ducts. Am J Pathol. 2000;156:1821\u20135.","journal-title":"Am J Pathol"},{"key":"3577_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518:495\u2013501.","journal-title":"Nature"},{"key":"3577_CR11","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell. 2017;32:185\u2013203.e13."},{"key":"3577_CR12","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/01.MP.0000086072.56290.FB","volume":"16","author":"A Maitra","year":"2003","unstructured":"Maitra A, Adsay NV, Argani P, Iacobuzio-Donahue C, De Marzo A, Cameron JL, et al. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol. 2003;16:902\u201312.","journal-title":"Mod Pathol"},{"key":"3577_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41568-023-00648-5","volume":"24","author":"M Fujii","year":"2024","unstructured":"Fujii M, Sekine S, Sato T. Decoding the basis of histological variation in human cancer. Nat Rev Cancer. 2024;24:141\u201358.","journal-title":"Nat Rev Cancer"},{"key":"3577_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/gutjnl-2019-318217","volume":"69","author":"NS Kalimuthu","year":"2020","unstructured":"Kalimuthu NS, Wilson GW, Grant RC, Seto M, O\u2019Kane G, Vajpeyi R, et al. Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome. Gut. 2020;69:317\u201328.","journal-title":"Gut"},{"key":"3577_CR15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt RA, Marayati R, Flate EL, Volmar KE, Loeza SG, Hoadley KA, et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015;47:1168\u201378.","journal-title":"Nat Genet"},{"key":"3577_CR16","doi-asserted-by":"publisher","first-page":"12214","DOI":"10.1096\/fj.202000363RR","volume":"34","author":"N Juiz","year":"2020","unstructured":"Juiz N, Elkaoutari A, Bigonnet M, Gayet O, Roques J, Nicolle R, et al. Basal-like and classical cells coexist in pancreatic cancer revealed by single-cell analysis on biopsy-derived pancreatic cancer organoids from the classical subtype. FASEB J. 2020;34:12214\u201328.","journal-title":"FASEB J"},{"key":"3577_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26059-4","volume":"12","author":"TG Krieger","year":"2021","unstructured":"Krieger TG, Le Blanc S, Jabs J, Ten FW, Ishaque N, Jechow K, et al. Single-cell analysis of patient-derived PDAC organoids reveals cell state heterogeneity and a conserved developmental hierarchy. Nat Commun. 2021;12:5826.","journal-title":"Nat Commun"},{"key":"3577_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1158\/0008-5472.CAN-22-3050","volume":"83","author":"HL Williams","year":"2023","unstructured":"Williams HL, Dias Costa A, Zhang J, Raghavan S, Winter PS, Kapner KS, et al. Spatially resolved single-cell assessment of pancreatic cancer expression subtypes reveals co-expressor phenotypes and extensive intratumoral heterogeneity. Cancer Res. 2023;83:441\u201355.","journal-title":"Cancer Res"},{"key":"3577_CR19","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","volume":"184","author":"S Raghavan","year":"2021","unstructured":"Raghavan S, Winter PS, Navia AW, Williams HL, DenAdel A, Lowder KE, et al. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell. 2021;184:6119\u201337.e26.","journal-title":"Cell"},{"key":"3577_CR20","doi-asserted-by":"crossref","unstructured":"Tamagawa H, Fujii M, Togasaki K, Seino T, Kawasaki S, Takano A, et al. Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma. Nat Cell Biol. 2024;26:1759\u201372.","DOI":"10.1038\/s41556-024-01498-5"},{"key":"3577_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.680435","volume":"12","author":"R Abou Khouzam","year":"2021","unstructured":"Abou Khouzam R, Rao SP, Venkatesh GH, Zeinelabdin NA, Buart S, Meylan M, et al. An eight-gene hypoxia signature predicts survival in pancreatic cancer and is associated with an immunosuppressed tumor microenvironment. Front Immunol. 2021;12:680435.","journal-title":"Front Immunol"},{"key":"3577_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.880810","volume":"13","author":"B Janji","year":"2022","unstructured":"Janji B, Chouaib S. The promise of targeting hypoxia to improve cancer immunotherapy: Mirage or reality? Front Immunol. 2022;13:880810.","journal-title":"Front Immunol"},{"key":"3577_CR23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015;161:933\u201345.","journal-title":"Cell"},{"key":"3577_CR24","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1126\/science.aaw6985","volume":"364","author":"D Tuveson","year":"2019","unstructured":"Tuveson D, Clevers H. Cancer modeling meets human organoid technology. Science. 2019;364:952\u20135.","journal-title":"Science"},{"key":"3577_CR25","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","volume":"8","author":"H Tiriac","year":"2018","unstructured":"Tiriac H, Belleau P, Engle DD, Plenker D, Desch\u00eanes A, Somerville TDD, et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discov. 2018;8:1112\u201329.","journal-title":"Cancer Discov"},{"key":"3577_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj SF, Hwang CI, Baker LA, Chio II, Engle DD, Corbo V, et al. Organoid models of human and mouse ductal pancreatic cancer. Cell. 2015;160:324\u201338.","journal-title":"Cell"},{"key":"3577_CR27","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.stem.2017.12.009","volume":"22","author":"T Seino","year":"2018","unstructured":"Seino T, Kawasaki S, Shimokawa M, Tamagawa H, Toshimitsu K, Fujii M, et al. Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression. Cell Stem Cell. 2018;22:454\u201367.e6.","journal-title":"Cell Stem Cell"},{"key":"3577_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1327772","volume":"12","author":"K Kumano","year":"2024","unstructured":"Kumano K, Nakahashi H, Louphrasitthiphol P, Kuroda Y, Miyazaki Y, Shimomura O, et al. Hypoxia at 3D organoid establishment selects essential subclones within heterogenous pancreatic cancer. Front Cell Dev Biol. 2024;12:1327772.","journal-title":"Front Cell Dev Biol"},{"key":"3577_CR29","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41592-024-02284-9","volume":"21","author":"Y Ma","year":"2024","unstructured":"Ma Y, Zhou X. Accurate and efficient integrative reference-informed spatial domain detection for spatial transcriptomics. Nat Methods. 2024;21:1231\u201344.","journal-title":"Nat Methods"},{"key":"3577_CR30","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1111\/cas.16283","volume":"115","author":"S Nagasawa","year":"2024","unstructured":"Nagasawa S, Zenkoh J, Suzuki Y, Suzuki A. Spatial omics technologies for understanding molecular status associated with cancer progression. Cancer Sci. 2024;115:3208\u201317.","journal-title":"Cancer Sci"},{"key":"3577_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13046-022-02301-9","volume":"41","author":"T Shinkawa","year":"2022","unstructured":"Shinkawa T, Ohuchida K, Mochida Y, Sakihama K, Iwamoto C, Abe T, et al. Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses. J Exp Clin Cancer Res. 2022;41:89.","journal-title":"J Exp Clin Cancer Res"},{"key":"3577_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411\u201320.","journal-title":"Nat Biotechnol"},{"key":"3577_CR33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/sj.bjc.6605450","volume":"102","author":"FM Buffa","year":"2010","unstructured":"Buffa FM, Harris AL, West CM, Miller CJ. Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene. Br J Cancer. 2010;102:428\u201335.","journal-title":"Br J Cancer"},{"key":"3577_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst"},{"key":"3577_CR35","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1158\/1078-0432.CCR-19-3724","volume":"26","author":"GM O\u2019Kane","year":"2020","unstructured":"O\u2019Kane GM, Gr\u00fcnwald BT, Jang GH, Masoomian M, Picardo S, Grant RC, et al. GATA6 expression distinguishes classical and basal-like subtypes in advanced pancreatic cancer. Clin Cancer Res. 2020;26:4901\u201310.","journal-title":"Clin Cancer Res"},{"key":"3577_CR36","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1136\/gutjnl-2023-329839","volume":"73","author":"C Tonelli","year":"2024","unstructured":"Tonelli C, Yordanov GN, Hao Y, Desch\u00eanes A, Hinds J, Belleau P, et al. A mucus production programme promotes classical pancreatic ductal adenocarcinoma. Gut. 2024;73:941\u201354.","journal-title":"Gut"},{"key":"3577_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-2","volume":"7","author":"RD Blumenthal","year":"2007","unstructured":"Blumenthal RD, Leon E, Hansen HJ, Goldenberg DM. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. BMC Cancer. 2007;7:2.","journal-title":"BMC Cancer"},{"key":"3577_CR38","doi-asserted-by":"crossref","unstructured":"Somerville TD, Biffi G, Da\u00dfler-Plenker J, Hur SK, He XY, Vance KE, et al. Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation. eLife. 2020;9:e53381.","DOI":"10.7554\/eLife.53381"},{"key":"3577_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101692","volume":"33","author":"M Dong","year":"2023","unstructured":"Dong M, Tang R, Wang W, Xu J, Liu J, Liang C, et al. Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable prognosis in pancreatic adenocarcinoma: hypoxia in PDAC. Transl Oncol. 2023;33:101692.","journal-title":"Transl Oncol"},{"key":"3577_CR40","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/ng.3391","volume":"47","author":"M Janiszewska","year":"2015","unstructured":"Janiszewska M, Liu L, Almendro V, Kuang Y, Paweletz C, Sakr RA, et al. In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer. Nat Genet. 2015;47:1212\u20139.","journal-title":"Nat Genet"},{"key":"3577_CR41","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/bjc.2015.284","volume":"113","author":"NC Dhani","year":"2015","unstructured":"Dhani NC, Serra S, Pintilie M, Schwock J, Xu J, Gallinger S, et al. Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole. Br J Cancer. 2015;113:864\u201371.","journal-title":"Br J Cancer"},{"key":"3577_CR42","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-11-1182","volume":"71","author":"K Toustrup","year":"2011","unstructured":"Toustrup K, S\u00f8rensen BS, Nordsmark M, Busk M, Wiuf C, Alsner J, et al. Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer. Cancer Res. 2011;71:5923\u201331.","journal-title":"Cancer Res"},{"key":"3577_CR43","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1158\/1078-0432.CCR-17-0038","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang L, Taylor J, Eustace A, Irlam JJ, Denley H, Hoskin PJ, et al. A gene signature for selecting benefit from hypoxia modification of radiotherapy for high-risk bladder cancer patients. Clin Cancer Res. 2017;23:4761\u20138.","journal-title":"Clin Cancer Res"},{"key":"3577_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1095812","volume":"14","author":"GA Walaas","year":"2023","unstructured":"Walaas GA, Gopalakrishnan S, Bakke I, Skovdahl HK, Flatberg A, \u00d8stvik AE, et al. Physiological hypoxia improves growth and functional differentiation of human intestinal epithelial organoids. Front Immunol. 2023;14:1095812.","journal-title":"Front Immunol"},{"key":"3577_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.stem.2009.08.001","volume":"5","author":"Y Yoshida","year":"2009","unstructured":"Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell. 2009;5:237\u201341.","journal-title":"Cell Stem Cell"},{"key":"3577_CR46","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/cdd.2011.172","volume":"19","author":"JC Estrada","year":"2012","unstructured":"Estrada JC, Albo C, Bengur\u00eda A, Dopazo A, L\u00f3pez-Romero P, Carrera-Quintanar L, et al. Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis. Cell Death Differ. 2012;19:743\u201355.","journal-title":"Cell Death Differ"},{"key":"3577_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh3375","volume":"8","author":"B Kumar","year":"2022","unstructured":"Kumar B, Adebayo AK, Prasad M, Capitano ML, Wang R, Bhat-Nakshatri P, et al. Tumor collection\/processing under physioxia uncovers highly relevant signaling networks and drug sensitivity. Sci Adv. 2022;8:eabh3375.","journal-title":"Sci Adv"},{"key":"3577_CR48","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.gastro.2019.05.004","volume":"157","author":"PC McDonald","year":"2019","unstructured":"McDonald PC, Chafe SC, Brown WS, Saberi S, Swayampakula M, Venkateswaran G, et al. Regulation of pH by carbonic anhydrase 9 mediates survival of pancreatic cancer cells with activated KRAS in response to hypoxia. Gastroenterology. 2019;157:823\u201337.","journal-title":"Gastroenterology"},{"key":"3577_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1158\/1078-0432.CCR-19-2926","volume":"26","author":"K Mehla","year":"2020","unstructured":"Mehla K, Singh PK. Metabolic subtyping for novel personalized therapies against pancreatic cancer. Clin Cancer Res. 2020;26:6\u20138.","journal-title":"Clin Cancer Res"},{"key":"3577_CR50","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ccell.2020.08.015","volume":"38","author":"L Gabitova-Cornell","year":"2020","unstructured":"Gabitova-Cornell L, Surumbayeva A, Peri S, Franco-Barraza J, Restifo D, Weitz N, et al. Cholesterol pathway inhibition induces TGF-\u03b2 signaling to promote basal differentiation in pancreatic cancer. Cancer Cell. 2020;38:567\u201383.e11.","journal-title":"Cancer Cell"},{"key":"3577_CR51","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ccell.2021.07.020","volume":"39","author":"V Veninga","year":"2021","unstructured":"Veninga V, Voest EE. Tumor organoids: opportunities and challenges to guide precision medicine. Cancer Cell. 2021;39:1190\u2013201.","journal-title":"Cancer Cell"},{"key":"3577_CR52","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1136\/gutjnl-2015-311256","volume":"66","author":"P Martinelli","year":"2017","unstructured":"Martinelli P, Carrillo-de Santa Pau E, Cox T, Sainz B Jr, Dusetti N, Greenhalf W, et al. GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer. Gut. 2017;66:1665\u201376.","journal-title":"Gut"},{"key":"3577_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18504-7","volume":"11","author":"N Gremke","year":"2020","unstructured":"Gremke N, Polo P, Dort A, Schneikert J, Elmsh\u00e4user S, Brehm C, et al. mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability. Nat Commun. 2020;11:4684.","journal-title":"Nat Commun"},{"key":"3577_CR54","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41420-023-01759-6","volume":"9","author":"VR Silva","year":"2023","unstructured":"Silva VR, Santos LS, de Castro MVL, Dias RB, Valverde LF, Rocha CAG, et al. A novel ruthenium complex with 5-fluorouracil suppresses colorectal cancer stem cells by inhibiting Akt\/mTOR signaling. Cell Death Discov. 2023;9:460.","journal-title":"Cell Death Discov"},{"key":"3577_CR55","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/s41388-022-02182-4","volume":"41","author":"S Steiner","year":"2022","unstructured":"Steiner S, Seleznik GM, Reding T, Stopic M, Lenggenhager D, Ten Buren E, et al. De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer. Oncogene. 2022;41:1507\u201317.","journal-title":"Oncogene"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03577-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03577-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03577-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:53:15Z","timestamp":1793890395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03577-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,11,20]]}},"alternative-id":["3577"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03577-w","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was received from all patients after approval by the Institutional Review Board of the University of Tsukuba Hospital (approval number: H28-090). Animal experiments were performed in accordance with approval from the Institutional Animal Care and Use Committee and the Regulation for Animal Experiments at the University of Tsukuba (approval number: 23-030). The study also conformed to the Fundamental Guidelines for Proper Conduct of Animal Experiments and Related Activities in Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology (Japan).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}